Market Outlook
The India Malaria Vaccine Market is poised for steady growth over the forecast period, driven by the persistent public health challenge posed by malaria and increasing governmental focus on its eradication. Valued at USD 38.21 million in 2024, the market is projected to reach USD 47.21 million by 2030, reflecting a compound annual growth rate (CAGR) of 3.59%. This expansion is underpinned by advancements in vaccine technology, heightened awareness of malaria prevention, and strateg